Mark Hillman
About Mark Hillman
Mark Hillman is the Associate Director of Business Capability Management at Bristol-Myers Squibb, with over two decades of experience in the pharmaceutical industry, including roles at DuPont Pharmaceuticals, Taratec Development Corporation, and Johnson & Johnson Merck.
Current Position at Bristol-Myers Squibb
Mark Hillman currently holds the title of Associate Director Business Capability Management at Bristol-Myers Squibb. In his role, he focuses on enhancing business capabilities to support the company's goals. His responsibilities involve strategic planning and process improvement aimed at increasing efficiency and effectiveness.
Professional Experience in Pharmaceutical Industry
Mark Hillman has an extensive career in the pharmaceutical industry. Before joining Bristol-Myers Squibb, he worked at DuPont Pharmaceuticals as Team Leader Preclinical R&D Systems. He also held the position of Sr Validation Consultant at Taratec Development Corporation. His career began at GE Government Services as a System Analyst, followed by various roles at Johnson & Johnson Merck and McNeil Consumer Healthcare.
Education and Mechanical Engineering Background
Mark Hillman studied Mechanical Engineering at Drexel University, where he earned his Bachelor of Science degree. His education laid a solid foundation for his diverse career in the pharmaceutical industry, where he has applied his engineering background in various technical and managerial roles.
Roles at Johnson & Johnson Merck
While working at Johnson & Johnson Merck, Mark Hillman held multiple positions including Sr Analyst and Process Engineer. He was based in Lancaster, Pennsylvania, where he contributed to process improvements and technical operations over a span of six years.
Focus on Patient Care and Safety
Mark Hillman is dedicated to improving patient care and safety within the pharmaceutical industry. He manages Risk Evaluation and Mitigation Strategies (REMS) programs and ensures patient access to investigational medicines through Pre-Approval Access programs. His efforts are directed towards ensuring the safe use of medications through rigorous controls and safety measures.